4.7 β’ 6K Ratings
ποΈ 21 December 2022
β±οΈ 11 minutes
ποΈ Recording | iTunes | RSS
π§ΎοΈ Download transcript
Click on a timestamp to play from that location
0:00.0 | You're listening to Shortwave from NPR. |
0:04.6 | Hippotheds, Aaron Scott here and today we are going to turn on and tune in to some |
0:11.7 | mind-bending brain science, which means we have MPR science correspondent John Hamilton. |
0:16.4 | Hello John. |
0:17.4 | Hello Aaron. |
0:18.7 | When we last talked a couple of weeks ago, you were on your way to the Society for Neuroscience |
0:23.5 | Meeting in San Diego. |
0:25.2 | Great, 23,000 brain scientists all in one convention center. |
0:30.1 | It is absolutely my favorite nerd fest. |
0:33.7 | What were all those brainiacs talking about? |
0:36.6 | Drugs Aaron, psychedelic drugs. |
0:39.6 | Okey-dokey. |
0:40.6 | Drugs like MDMA, also known as ecstasy and psilocybin. |
0:44.7 | That's the chemical that makes magic mushrooms magic. |
0:47.6 | Of course there's also LSD and plant-based hallucinogens like salvia, ayahuasca, ibogaine. |
0:54.8 | John, you are starting to sound like a friendly drug dealer at Burning Man here. |
0:59.0 | Yeah, it might sound like it, but I'm talking about a scientific meeting here. |
1:03.8 | Brain scientists are looking at psychedelic drugs because these chemicals may be the key |
1:08.6 | to a whole new way of treating psychiatric disorders. |
1:11.8 | I'm talking about problems like anxiety, depression, PTSD, substance abuse, obsessive-compulsive |
1:18.4 | disorder, even chronic pain. |
1:21.3 | These drugs also offer a way to study things like learning and consciousness. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright Β© Tapesearch 2025.